Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Not all profitable companies are created equal, and that’s why we built StockStory - to help you find the ones that truly shine bright. That said, here are three profitable companies that don’t make the cut and some better opportunities instead.

Kadant (KAI)

Trailing 12-Month GAAP Operating Margin: 15%

Headquartered in Massachusetts, Kadant (NYSE: KAI) is a global supplier of high-value, critical components and engineered systems used in process industries worldwide.

Why Is KAI Not Exciting?

1. Sales trends were unexciting over the last two years as its 7% annual growth was below the typical industrials company
2. Incremental sales over the last two years were less profitable as its 4% annual earnings per share growth lagged its revenue gains
3. Eroding returns on capital suggest its historical profit centers are aging

Kadant’s stock price of $265.68 implies a valuation ratio of 21.1x forward P/E. Dive into our free research report to see why there are better opportunities than KAI.

Richardson Electronics (RELL)

Trailing 12-Month GAAP Operating Margin: 2.5%

Founded in 1947, Richardson Electronics (NASDAQ: RELL) is a distributor of power grid and microwave tubes as well as consumables related to those products.

Why Are We Cautious About RELL?

1. Muted 5.3% annual revenue growth over the last five years shows its demand lagged behind its industrials peers
2. Weak free cash flow margin of -0.9% has deteriorated further over the last five years as its investments increased
3. Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions

Richardson Electronics is trading at $16.06 per share, or 33x forward P/E. Read our free research report to see why you should think twice about including RELL in your portfolio.

GE HealthCare (GEHC)

Trailing 12-Month GAAP Operating Margin: 12.9%

Spun off from industrial giant General Electric in 2023 after over a century as its healthcare division, GE HealthCare (NASDAQ: GEHC) provides medical imaging equipment, patient monitoring systems, diagnostic pharmaceuticals, and AI-enabled healthcare solutions to hospitals and clinics worldwide.

Why Does GEHC Give Us Pause?

1. Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
2. Projected sales growth of 4.4% for the next 12 months suggests sluggish demand
3. Expenses have increased as a percentage of revenue over the last five years as its adjusted operating margin fell by 1.7 percentage points

At $64.74 per share, GE HealthCare trades at 12.5x forward P/E. If you’re considering GEHC for your portfolio, see our FREE research report to learn more.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like Find your next big winner with StockStory today.